Medicinal Product Shortages – update – 15 September 2021

Notice type: Advisory

Date: 15/09/2021


Further Information:

The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Betnesol 0.1%w/v Eye, Ear and Nasal Drops - PA1638/001/001
  • Creon for Children 5000 Gastro Resistant Granules - PA2010/008/004
  • Dioralyte Blackcurrant Powder for Oral Solution (20 pack) – PA0540/098/001
  • Dioralyte Citrus Powder for Oral Solution (20 pack) - PA0540/098/002
  • Dioralyte Rebalance Citrus Powder for Oral Solution (6 pack) - PA0540/194/002
  • Integrilin 0.75mg/ml Solution for Infusion - EU/1/99/109/001
  • MST Continus 5mg Prolonged Release Tablets – PA1688/004/001
  • MST Continus 10mg Prolonged Release Tablets - PA1688/004/002
  • RoActemra 162mg Solution for Injection in Pre Filled Syringe - EU/1/08/492/007
  • Sotoger 80mg Tablets - PA0577/021/001
  • Telmisartan Rowa 40mg Tablets - PA0074/078/002
  • Ultraproct 0.92mg/ + 0.95mg/g + 5mg/g Rectal Ointment - PA22650/004/001


The following shortages have been resolved and supply has resumed to the Irish market:

  • Angeliq 1mg/2mg Tablet - PA1410/013/001
  • Ciprofloxacin 2mg/ml Solution for Infusion - PA1122/005/001
  • Ibandronic Acid Mylan 150mg Film Coated Tablets - PA0577/111/001
  • Lyrica 75mg Hard Capsules - EU/1/04/279/011-013
  • Metalyse 10,000 Units Powder and Solvent for Solution for Injection - EU/1/00/169/006
  • OxyNorm 5mg Hard Capsules - PA1688/006/004
  • Targin 15 mg/7.5 mg Prolonged Release Tablets - PA1688/010/006


Please see the shortages section of the HPRA website for further information.

The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

« Back